Skip to content

The Effect of Esomeprazole on Postoperative Recovery Quality in Female Patients Undergoing Thyroidectomy

The Effect of Esomeprazole on Postoperative Recovery Quality in Female Patients Undergoing Thyroidectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111115
Enrollment
Unknown
Registered
2025-10-27
Start date
2025-11-20
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female Thyroid Surgery

Interventions

Group E:Administer esomeprazole 40 mg intravenously over 3 minutes 30 minutes prior to induction of anesthesia (dissolve one vial of esomeprazole 40 mg lyophilized powder in 5 mL of normal saline).
Group C:Administer 5 mL of normal saline via intravenous injection over 3 minutes 30 minutes prior to anesthesia induction.

Sponsors

Anqing Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age 18–65 years; 2. BMI 18–30 kg/m^2; 3.ASA I–III; 4.Female patients scheduled for elective thyroidectomy under general anesthesia; 5.History of motion sickness or PONV; 6.No gastrointestinal disease; no prior gastrointestinal surgery except simple cholecystectomy; 7.Normal communication ability; 8. Voluntary participation and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Allergy to esomeprazole; 2.Administration of antiemetics or analgesics within 24 hours prior to surgery; 3.Use of H2 receptor antagonists or PPIs; 4.Use of medications interacting with esomeprazole (e.g., phenytoin, diazepam, ketoconazole, itraconazole, warfarin/vitamin K antagonists, clopidogrel); 5.Use of antipsychotic drugs or corticosteroids; 6.History of heart failure or arrhythmia; uncontrolled hypertension; diabetes with poor glycemic control; hepatic or renal impairment; gastrointestinal motility disorders; vestibular disorders; 7. Pregnant or lactating women; 8.Unable to understand the Quality of Recovery-15 (QoR-15)/Visual Analogue Scale (VAS)

Design outcomes

Primary

MeasureTime frame
Preoperative and 24-Hour Postoperative Quality of Recovery-15 (QoR-15) Score;

Secondary

MeasureTime frame
Incidence of PONV at 1 hour, 6 hours, and 24 hours postoperatively;Postoperative pain VAS scores at 1 hour, 6 hours, and 24 hours;Use of rescue antiemetics and rescue analgesics;Postoperative Ramsay Sedation Scale in the PACU and PACU Stay Duration;First passage of gas/bowel movement; Length of hospital stay First passage of gas/bowel movement; Length of hospital stay;Severity of PONV;

Countries

China

Contacts

Public ContactWu Xiongzhi

Anqing Municipal Hospital

wuxz202306@163.com+86 155 5121 2726

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026